A updated issue brief examines the most recent data on deaths from COVID-19 and other causes, and finds that COVID-19 is currently the number one cause of death in the United States. As of February 20, 2021, an average of more than 2,400 people per day died of COVID-19 in…
The Peterson-KFF Health System Tracker provides clear, up-to-date information on trends, drivers and issues that impact the performance of the system. It also illustrates how the U.S. is performing relative to other countries and how different parts of the system are performing relative to one another. A partnership of the Peterson Center on Healthcare and the KFF, the Tracker’s work goal places a heavy emphasis on data and evidence, addressing key questions through collections of charts, which provide data with additional context and synthesis of the latest research and developments. The Tracker also provide regular insight briefs for a more in-depth look at topical questions.
Featured Peterson-KFF Resources
This chart collection summarizes what is known so far about how health costs and utilization have changed during the COVID-19 pandemic. Health spending is on track to be somewhat lower in 2020 than in 2019 – the first time that’s happened since the government started tracking it.
Issue Brief See More
Related Peterson-KFF Resources
- How Prepared is the U.S. to Respond to COVID-19 Relative to Other Countries?
- Potential Costs of Coronavirus Treatment for People with Employer Coverage
- How Health Costs Might Change with COVID-19
- Visualizing Health Policy: US Statistics on Surprise Medical Billing
- Surprise Bills Vary by Diagnosis and Type of Admission
- How do healthcare prices and use in the U.S. compare to other countries?
- Health System Dashboard
- Household Health Spending Calculator
- National Health Spending Explorer
- How have healthcare prices grown in the U.S. over time?
- How much is health spending expected to grow?
- What are the recent and forecasted trends in prescription drug spending?
- An analysis of out-of-network claims in large employer health plans
- A Look at How the Opioid Crisis Has Affected People with Employer Coverage
- How Does Cost Affect Access to Care?
The coronavirus outbreak has hit densely populated urban areas of the United States first and hardest. Some health systems have experienced surges of patients, raising concerns that there are not enough hospital beds, staffing, and equipment. The novel coronavirus was slower to spread to rural areas in the U.S., but…
Issue Brief See More
- view as grid
- view as list
A new issue brief shows where Americans typically get flu vaccines in the U.S. and how much it costs to administer flu and other vaccines. Among the analysis’ findings: while most people get flu vaccines at a doctor’s office or retail health clinic, White people are more likely than Black,…
Analysis Examines the Implications of Price Transparency for Providers and Patients as New Rules Go into Effect
A new KFF analysis examines how new federal rules on price transparency for health services may affect patient decision-making and market pricing. As of January 1, 2021, the United States Department of Health and Human Services requires that hospitals publish payer-negotiated rates for common services on their websites. A second…
A new Peterson-KFF analysis examines the potential impact of new federal price transparency rules on patient decision-making and market pricing for health services. The brief also includes new analysis of geographic variation in health prices.
The Health Spending Explorer on the Peterson-KFF Health System Tracker helps users examine five decades worth of numbers documenting expenditures by federal and local governments, private insurers, and individuals on 15 categories of health services, including hospitals, physician and clinic care, and prescription drugs.
The Peterson-KFF Health System Dashboard examines the U.S. health system’s performance in four areas: access and affordability, health and well-being, health spending, and quality of care. Users can explore trends over time, as well as disparities and differences across demographic groups.
An updated issue brief estimates the number of enrollees in individual and fully-insured group market plans that have waived cost-sharing – out-of-pocket costs including coinsurance, copayments, and deductibles – for COVID-19 treatment. The analysis also estimates the number of enrollees whose insurer is offering various forms of premium payment relief.…
Analysis: COVID-19 Ranks as a Top 3 Leading Cause of Death in the U.S., Higher than in Almost All Other Peer Countries
A new KFF analysis examines leading causes of death and mortality rates in the United States and comparable countries. The U.S. has a higher COVID-19 mortality rate than many of its peer countries, with COVID-19 ranking as the nation’s third-leading cause of death in 2020, behind only heart disease and…